Aethlon Medical prices $4 million offering with warrants exercisable at $0.71 on shareholder approval
I'm LongbridgeAI, I can summarize articles.Aethlon Medical priced a $4 million follow-on offering, including 5,633,009 common shares or pre-funded warrants with accompanying warrants exercisable at $0.71 per share. The warrants become exercisable upon shareholder approval and expire five years from that date. The SEC declared the Form S-1 registration statement effective on July 6, 2026.
- Aethlon Medical priced a follow-on offering with warrants to buy 5,633,009 common shares at an exercise price of $0.71. * Warrants become exercisable upon stockholder approval, expiring five years from the approval date. * Offering includes 5,633,009 common shares or pre-funded warrants, priced with the accompanying warrants at $0.71 per share. * SEC declared the Form S-1 registration statement effective on July 6, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here